Kolexia
De Montalembert Mariane Médecine générale
De Montalembert Mariane
Médecine générale
Hôpital Necker Enfants Malades
Paris, France
233 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Drépanocytose Anémie Thalassémie Accident vasculaire cérébral Bêta-Thalassémie Hémopathies Hémoglobinopathies Surcharge en fer Priapisme

Collaborateurs

Voir plus
Brousse Valentine
Brousse Valentine
Hôpital Robert-Debré, Paris, France
Allali Slimane
Allali Slimane
Hôpital Necker Enfants Malades, Paris, France
Joseph Laure
Joseph Laure
Hôpital Necker Enfants Malades, Paris, France
Arlet Jean-Benoit
Arlet Jean-Benoit
Hôpital Européen Georges Pompidou, Paris, France

Industries

Voir plus
Novartis
36 collaboration(s)
Dernière en 2022
Vertex
14 collaboration(s)
Dernière en 2023
Edimark
4 collaboration(s)
Dernière en 2022
GLOBAL BLOOD THERAPEUTICS GMBH
2 collaboration(s)
Dernière en 2022

Dernières activités

Voir plus
A Safety and Efficacy Study Evaluating CTX001 in Subjects With Severe Sickle Cell Disease: A Phase 1/2/3 Study to Evaluate the Safety and Efficacy of a Single Dose of Autologous CRISPR-Cas9 Modified CD34+ Human Hematopoietic Stem and Progenitor Cells (CTX001) in Subjects With Severe Sickle Cell Disease
Essai Clinique (Vertex)   20 mars 2024
Elimination of Vaso-Occlusive Crises after Exagamglogene Autotemcel in Patients with Severe Sickle Cell Disease
Abstracts from the 2024 Tandem Meetings of ASTCT and CIBMTR, February 21-24, 2024, San Antonio, Texas, USA   01 février 2024
Hydroxyurea is associated with later onset of acute splenic sequestration crisis in sickle cell disease: Lessons from the European Sickle Cell Disease Cohort-Hydroxyurea (ESCORT-HU) study.
American journal of hematology   22 janvier 2024
Long-term Follow-up of Subjects With Sickle Cell Disease Treated With Ex Vivo Gene Therapy Using Autologous Hematopoietic Stem Cells Transduced With a Lentiviral Vector
Essai Clinique (Bluebird)   08 janvier 2024
A Safety and Efficacy Study Evaluating CTX001 in Subjects With Transfusion-Dependent β-Thalassemia: A Phase 1/2/3 Study of the Safety and Efficacy of a Single Dose of Autologous CRISPR-Cas9 Modified CD34+ Human Hematopoietic Stem and Progenitor Cells (hHSPCs) in Subjects With Transfusion-Dependent β-Thalassemia
Essai Clinique (Vertex)   21 décembre 2023
Disponibilité et coût des traitements de base de la drépanocytose dans 13 pays africains
87e CONGRÈS FRANÇAIS DE MÉDECINE INTERNE   01 décembre 2023
Reduced splenic function can mimic artemisinin resistance in severe malaria.
Journal of travel medicine   13 novembre 2023
Safety Profile of Crizanlizumab 5.0 Mg/Kg in Sickle Cell Disease: Pooled Data from Clinical Trials
65th ASH Annual Meeting Abstracts   02 novembre 2023
Availability and Cost of Basic Drugs for Sickle Cell Disease in 13 African Countries
65th ASH Annual Meeting Abstracts   02 novembre 2023
Exagamglogene Autotemcel for Severe Sickle Cell Disease
65th ASH Annual Meeting Abstracts   02 novembre 2023